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Notch1 Regulates Maturation
of CD41 and CD81 Thymocytes
by Modulating TCR Signal Strength
teolytically cleaved from the transmembrane portion
(Kidd et al., 1998; Schroeter et al., 1998; De Strooper et
al., 1999; Song et al., 1999; Struhl and Grenwald, 1999)
and translocated to the nucleus (Lecourtois and
Schweisguth, 1998; Struhl and Adachi, 1998), where it
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interacts with a transcriptional repressor, known as CSL*Department of Pathology and Laboratory Medicine
(for CBF-1, Suppressor of Hairless, and Lag-1) (Fortini† Institute of Medicine and Engineering
and Artavanis-Tsakonas, 1994; Jarriault et al., 1995).‡Abramson Family Cancer Institute
After binding Notch, CSL becomes a transcriptional acti-University of Pennsylvania Medical Center
vator, and in conjunction with the activity of other cofac-Philadelphia, Pennsylvania 19104
tors, including SKIP, PCAF, and/or GCN5, induces§Department of Biology
transcription of downstream targets (Delidakis and Arta-Haverford College
vanis-Tsakonas, 1992; Stifani et al., 1992; Kurooka andHaverford, Pennsylvania 19041
Honjo, 2000; Zhou et al., 2000). Notch signaling also
occurs through a poorly understood pathway that is
likely to involve interaction of Notch with Deltex (Dieder-Summary
ich et al., 1994; Matsuno et al., 1998).
A number of studies have demonstrated that Notch1Notch signaling regulates cell fate decisions in multi-
regulates the development of mammalian T cells. Notch1ple lineages. We demonstrate in this report that ret-
is dynamically expressed in developing thymocytesroviral expression of activated Notch1 in mouse
(Hasserjian et al., 1996) and appears to influence multi-thymocytes abrogates differentiation of immature
ple branch-points during T cell differentiation (reviewedCD41CD81 thymocytes into both CD4 and CD8 mature
in Deftos and Bevan, 2000; Di Santo et al., 2000; Ro-single-positive T cells. The ability of Notch1 to inhibit
thenberg, 2000). Specifically, Notch1 is highly expressedT cell development was observed in vitro and in vivo
in CD4282 (double-negative [DN]) precursors but is al-with both normal and TCR transgenic thymocytes.
most absent in immature (CD241) CD4181 (double-posi-Notch1-mediated developmental arrest was dose de-
tive [DP]) thymocytes (Hasserjian et al., 1996). Expres-pendent and was associated with impaired thymocyte
sion is restored to intermediate levels after maturationresponses to TCR stimulation. Notch1 also inhibited
of thymocytes into single-positive (SP) CD41 and CD81TCR-mediated signaling in Jurkat T cells. These data
T cells.indicate that constitutively active Notch1 abrogates
The importance of Notch1 in commitment of earlyCD41 and CD81 maturation by interfering with TCR
progenitors to the T cell lineage is underscored by twosignal strength and provide an explanation for the
recent studies. T cells fail to develop in inducible Notch1physiological regulation of Notch expression during
knockout mice (Radtke et al., 1999). Reciprocally, wethymocyte development.
have demonstrated that expression of active Notch1 in
stem cells induces ectopic CD4181 development in the
Introduction bone marrow (BM) and inhibits early B cell development
(Pui et al., 1999).
Notch proteins are a family of transmembrane receptors Notch has also been shown to regulate lineage com-
that play a pivotal role in regulating interpretation of mitment at other stages in T cell development. Reduc-
environmental signals in a wide variety of cell types and tion in expression of Notch biases development to the
species (Artavanis-Tsakonas et al., 1995, 1999). Notch TCRgd (versus TCRab) lineage (Washburn et al., 1997).
acts in a dose-dependent manner (Vassin et al., 1985; Transgenic Notch1 under control of the proximal lck
de la Concha, 1988) and influences cell fate through promoter also influences the CD4 versus CD8 decision,
lateral inhibition and/or by modulating the activity of although its precise role is controversial. In one study,
other signaling cascades (Sawamoto and Okano, 1996; a truncated version of intracellular Notch biased devel-
Weinmaster, 1998). Notch’s influence on cell differentia- opment toward the CD8 lineage (Robey et al., 1996). A
tion is reflected by its involvement in the regulation of recent report using a Notch construct containing addi-
neoplasia, proliferation, and apoptosis (Ellisen et al., tional sequence in the intracellular domain indicated
1991; Pear et al., 1996; Berry et al., 1997; Deftos et al., that Notch permits development to both CD4 and CD8
1998; Jehn et al., 1999). lineages but also biases development to the CD8 SP
Notch1, one of four family members, binds multiple phenotype (Deftos et al., 2000). A third study showed
ligands, including Delta/Serrate and Jagged (Betten- that inhibiting Notch1 activity abrogates CD8 but not
hausen et al., 1995; Lindsell et al., 1995; Shawber et al., CD4 development (Yasutomo et al., 2000). The mecha-
1996; Dunwoodie et al., 1997; Weinmaster, 2000). After nism by which Notch alters DP to SP maturation is poorly
ligand binding, the intracellular region of Notch1 is pro- understood.
Here, we report that expression of the entire intracellu-
lar Notch1 coding region (ICN1) under control of thek To whom correspondence should be addressed (e-mail: wpear@
retroviral LTR inhibits positive selection of both CD41mail.med.upenn.edu).
# These authors contributed equally to this work. and CD81 T cells from their DP CD4181 precursors in
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Figure 1. Activated Notch1 Inhibits SP CD4 and CD8 Development at the CD4181 Stage In Vivo
Lethally irradiated B6 mice received BM transduced with MigR1 or MigICN1 (full-length intracellular Notch), and their thymocytes were analyzed
by flow cytometry using GFP, CD4, and CD8 antibodies 29 days later. CD4 versus CD8 FACS contour plots of (A) MigR1 control thymus and
(B) Notch1 thymus. (C) FSC overlay plots of CD4181 MigR1 control thymus and Notch1 thymus. (D) TCR expression of CD4181 MigR1 control
thymus and Notch1 thymus. (E) GFP expression of MigR1 control thymus and Notch1 thymus. The y axis of each histogram represents cell
number.
vivo and in vitro. Our findings also show that Notch by reconstituting lethally irradiated mice with BM trans-
duced with Mig ICN1 or the GFP-expressing controlactivity results in decreased responsiveness of thymo-
cytes to TCR signals, as measured by CD5 and CD69 vector, MigR1. DP thymocytes develop both intrathymi-
cally and ectopically in these chimeras and are presentupregulation. We directly confirm that Notch1 modu-
lates TCR signaling by showing that Notch1 inhibits in BM, spleen, and thymus (Pui et al., 1999). Within 1
month following reconstitution, all DP populations re-TCR-mediated NFAT/AP-1 promoter activity in Jurkat T
cells. These data together indicate that Notch1 regulates semble wild-type thymocytes with respect to size, cell
cycle status, and levels of TCR expression (Figures 1Cthe DP to SP transition by influencing TCR signal
strength and suggest a unifying model that may help and 1D; data not shown).
We first compared the CD4/CD8 phenotype of controlresolve apparent differences among published observa-
tions concerning the role of Notch in CD4 versus CD8 and ICN11 thymocyte populations 29 days after recon-
stitution, distinguishing transduced from wild-type cellscommitment.
by GFP expression (Figures 1A–1D). As reported pre-
viously, ICN11 cells present in the BM and spleen hadResults
an immature CD41CD81 phenotype; no mature SP cells
were evident (Pui et al., 1999; data not shown). Similarly,Constitutively Active Notch1 Inhibits Mature
CD4 and CD8 Differentiation In Vivo the ICN11 DP thymocytes were markedly inhibited in
their ability to develop into both CD41 and CD81 matureWe examined the influence of retrovirally expressed in-
tracellular Notch1 (ICN1) on T cell development in vivo single-positive cells (Figure 1B).
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pressed low levels of TCR and CD69 and high levels
of HSA, indicating that this population is comprised of
immature single-positive (ISP) thymocytes (Figures 3C
and 3D). These data reveal that ICN1 expression abro-
gated the DP to SP transition, regardless of lineage, and
are consistent with our in vivo results demonstrating an
ICN1-mediated block at the DP stage of maturation.
Activated Notch1 Inhibits Development
of Thymocytes Expressing Either MHC
Class I– or Class II–Restricted TCR
To address the possibility that the block in T cell devel-
opment observed in ICN1 DP thymocytes was due to
latent skewing of TCR repertoire specificities, we exam-
ined the influence of Notch1 expression in TCR trans-
Figure 2. ICN1 DP Thymocytes Injected Intrathymically Fail to Dif- genic thymocytes. We transduced BM from MHC class
ferentiate in a Normal Thymic Microenvironment II– and MHC class I–restricted TCR transgenic mice
CD4 versus CD8 FACS contour plots of (A) control tNGFR2 thymic (OVA-specific DO11.10 and male antigen-specific H-Y,
DP and (B) ICN1 tNGFR1 thymic DP were isolated 4 weeks post- respectively) with ICN1 retrovirus and reconstituted le-
transplant and injected into thymi of unirradiated CD45.1 congenic thally irradiated recipients of the appropriate positively
mice and analyzed by flow cytometry using NGFR, CD45.2, CD4,
selecting MHC background. Consistent with our previ-and CD8 antibodies 3 days later. For this experiment, ICN was
ous observations, ICN1 expression significantly im-expressed from the MSCV ires tNGFR retroviral vector, which utilizes
paired CD4 development of DO11.10 TCR T cells (Fig-the human truncated nerve growth factor receptor, in place of GFP,
as a surrogate marker. In all assays performed to date, MigR1 and ures 4A–4C). Although CD8 SP cells were present in
MSCV ires tNGFR have produced identical results. The results are ICN1 H-Y TCR transgenic recipients, they expressed
representative of four recipients from two independent experiments. low levels of the TCR transgene and were significantly
larger than control mature CD8 SP cells, indicating again
that they represented immature CD8 SP precursors (Fig-
DP Thymocytes that Express Activated Notch1 Fail ures 5A and 5B). Indeed, when thymocytes were elec-
to Differentiate following Intrathymic Injection tronically gated on small cells, which is indicative of the
To directly determine the developmental potential of most mature populations, the ability of ICN1 to abrogate
purified ICN1-expressing DP cells in a normal unirradi- CD8 development was marked (Figure 5C). These find-
ated thymic environment, we isolated thymic DP cells ings rule out the possibility that TCR repertoire skewing
from CD45.2 ICN1 chimeras and injected them into underlies the ICN1 inhibition of development and further
the thymus of normal unirradiated CD45.1 congenic re- support our observations that Notch1 can inhibit devel-
cipients. Three days after injection, transduced and opment of both CD4 and CD8 lineages.
nontransduced donor cells were identified by CD45.2
expression and expression of a surrogate marker, trun- Activated Notch1 Inhibits In Vitro Maturation
cated nerve growth factor receptor (tNGFR) (see Experi- in a Dose-Dependent Manner
mental Procedures). Whereas tNGFR-DP cells devel- To determine if direct stimulation of ICN11 thymocytes
oped into both CD4 and CD8 SP cells over the 3 day could induce maturation, we took advantage of an in
period, tNGFR1 thymic DP cells transduced with ICN1 vitro system of maturation that drives differentiation of
did not differentiate into either CD4 or CD8 lineages DP thymocytes. Stimulation of purified DP thymocytes
(Figure 2). Ectopically developing DP thymocytes puri- with immobilized antibodies specific for TCR and CD2
fied from the BM of ICN1 chimeras also failed to differen- induces development of DP cells to the CD4 phenotype
tiate into either lineage (data not shown). These data (Cibotti et al., 1997; Brugnera et al., 2000). We stimulated
indicate that ICN11 DP thymocytes have a reduced wild-type and ICN11 DP populations with immobilized
potential to differentiate into both CD4 and CD8 lin- anti-TCR and anti-CD2 and allowed cells to recover in
eages, even in a normal thymic environment. the absence of stimulation (Cibotti et al., 1997). Although
wild-type DP thymocytes efficiently differentiated into
CD4 SP T cells, ICN11 thymic DP thymocytes wereNotch1 Activity Inhibits CD4 and CD8 Differentiation
in FTOC impaired in their ability to mature and ICN11 BM-
derived DP cells were completely inhibited from devel-To refine our analysis of the developmental potential of
ICN11 T cell precursors in the thymic microenviron- oping (Figures 6A and 6B).
To more directly address the implication that Notch1’sment, we reconstituted fetal thymic organ cultures
(FTOC) with fetal liver-derived hematopoietic stem cells effect on DP maturation was dose dependent and not
related to the microenvironment from which the DP cellsthat had been transduced with ICN1 and control vectors.
After reconstitution, fetal thymic lobes were cultured for were isolated, we purified DP ICN11 cells expressing
different levels of GFP (Notch) from the thymus of recon-16 days and cell suspensions were analyzed by flow
cytometry. As observed in vivo, ICN1 dramatically inhib- stituted hosts and compared their maturation potential
with wild-type and BM-derived DP thymocytes (Figureited CD4 development in FTOC (Figures 3A and 3B).
Although the percentage of CD8 SP cells increased in 6D). BM-derived DP cells expressed the highest levels
of GFP and failed to mature to the CD4 SP phenotype.ICN1 FTOC, these cells were larger than controls, ex-
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Figure 3. Activated Notch1 Blocks T Cell De-
velopment In Vitro
Irradiated d15 fetal thymic lobes were recon-
stituted with fetal liver cells expressing either
control vector or ICN1 and cultured for 16
days. FACS contour plots and histograms of
fetal thymic organ cultures reconstituted with
fetal liver cells expressing control vector (A)
or ICN1 (B) analyzed using GFP and abTCR,
CD4, and CD8 antibodies. ICN1-expressing
thymocytes were inhibited from differentiat-
ing to mature TCRhi SP CD4 and CD8 T cells.
The CD8 SP cells that accumulate in Notch
FTOC are phenotypically immature as de-
fined by TCR, high expression of HSA, lack
of expression of CD69 (C), and large cell size
(D). The percentage of gated cells and/or me-
dian fluorescence intensity is indicated in the
histograms. The y axis of each histogram rep-
resents cell number. The results are repre-
sentative of four independent experiments.
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our results indicate that Notch abrogates TCR-induced
maturation, we assessed the influence of ICN1 expres-
sion on TCR signaling by measuring TCR-mediated
upregulation of CD5 and CD69, sensitive indicators of
TCR stimulation and thymocyte differentiation (Kearse
et al., 1995; Punt et al., 1996; Lucas and Germain, 2000).
The ability of purified DP thymocytes to upregulate CD5
in response to TCR/CD2 coengagement was abrogated
in purified DP ICN11 populations from both the thymus
and BM. BM-derived DP thymocytes, which express the
highest levels of Notch1, are most markedly inhibited in
their ability to upregulate CD5 (Figure 7C). Thymic DP
cells expressing lower levels of Notch1 upregulated CD5
to a greater extent but less efficiently than wild-type DP
cells.
Increased Notch expression also abrogated CD69 ex-
pression in thymic DP thymocytes expressing different
levels of Notch1 (Figure 6D). Again, the effect of Notch on
activation was dose dependent: the thymic population
expressing the highest ICN1 levels were most impaired
in their ability to upregulate CD69 (Figure 7D). These
data, together with results from Figure 6, indicate that
the ability of DP cells to both mature and to respond to
acute TCR stimulation by upregulating CD5 or CD69
correlated inversely with levels of ICN1 expression. To-Figure 4. Activated Notch1 Inhibits CD4 Development of the
DO11.10 MHC Class II–Restricted TCR gether, these results raise the intriguing possibility that
Notch influences T cell development by modulating TCR5-FU-treated bone marrow from DO11.10 TCR transgenic mice was
retrovirally transduced with MigR1 or ICN1, injected into lethally signaling efficiency.
irradiated BALB/c mice, and analyzed by flow cytometry between
days 25–42 post BMT using GFP and clonotype TCR, CD4, and
Activated Notch1 Inhibits NFAT/AP-1 PromoterCD8 antibodies. FACS contour plot of (A) unmanipulated DO11.10
Activity in Jurkat Cellsthymocytes, (B) DO11.10 thymocytes expressing control vector, and
To directly examine the influence of Notch1 on down-(C) DO11.10 thymocytes expressing Notch1. Numbers in the upper
left quadrants of each plot indicate the percentage of CD4 SP for that stream targets of TCR signaling, we assayed the influ-
particular plot. ICN11 and control DP cells expressed comparable ence of ICN1 on TCR stimulation of Jurkat cells in vitro.
levels of transgenic TCR in both cases. The results are representa- Stimulation of the TCR on Jurkat T cells results in the
tive of two independent experiments.
transactivation of the IL-2 gene, which can be measured
using a transfectable luciferase reporter construct en-
coding multiple copies of the NFAT/AP1 region of theGFPhi DP thymocytes matured less efficiently than GFPlo
IL-2 promoter (Durand et al., 1987). Notably, ICN1 ex-DP thymocytes and wild-type DP cells (Figure 6E). These
pression significantly and specifically inhibited NFAT/results demonstrated an inverse correlation between the
AP1 promoter activity in response to either plate-boundefficiency with which DP cells differentiated to the CD4
anti-TCR or pharmacologic mimics of TCR signaling,phenotype and level of ICN1 (GFP) expression (Fig-
PMA and ionomycin. (Figure 7E). The inhibition was doseure 6D).
dependent (data not shown). ICN1 is not a general tran-The extent to which CD4 differentiation was impaired
scriptional repressor as ICN1 has no effect on either thein ICN11 populations correlated with the level of Notch
Pax5 or EBF promoters (Pui et al., 1999). Therefore,expressed in each population, as assessed by levels of
these data confirm that Notch1 abrogates TCR signalingGFP expression (Figures 6C and 6D). Our previous re-
and support our hypothesis that Notch1 controls T cellsults and our analysis of different GFP populations in
development by modulating TCR signal strength.the thymus demonstrate a linear relationship between
levels of expression of the surrogate marker GFP and
levels of expression of the Notch protein (Pui et al., 1999; Discussion
data not shown). To directly verify that GFP intensity is
a reliable indicator of Notch expression in our system, In this report, we show that high levels of Notch1 activity
in developing T cells impair maturation of DP cells intowe stained thymocyte populations sorted on the basis
of GFP expression for intracellular Notch (Figures 7A both CD41 and CD81 mature SP lineages. Notch-medi-
ated developmental arrest is not due to extrathymicand 7B). These data demonstrate a direct correlation
between the level of GFP fluorescence and ICN1 protein influences, as developmental arrest is observed after
intrathymic injection and in reconstituted fetal thymicexpression.
organ cultures. In addition, developmental arrest was
not due to a skewed TCR repertoire as ICN11 DP cellsActivated Notch1 Abrogates Acute
TCR-Mediated Responses expressing transgenic TCR restricted to MHC class I or
MHC class II also were inhibited from developing to theT cell maturation and lineage commitment are governed
by TCR signaling (Alberola-Ila et al., 1997). Because mature SP stage. In vitro maturation assays verified the
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Figure 5. Activated Notch1 Inhibits CD8 Development of the H-Y MHC Class I–Restricted TCR
5-FU-treated bone marrow from H-Y TCR transgenic mice was retrovirally transduced with MigR1 or ICN1, injected into lethally irradiated B6
mice, and analyzed by flow cytometry between days 25–42 post BMT using GFP and clonotype T3.70 TCR, CD4, and CD8 antibodies. (A)
CD4 versus CD8 FACS contour plot of H-Y thymocytes expressing control vector or Notch1. (B) CD8 SP cells in Notch-expressing H-Y TCR
are immature as they have lower clonotypic TCR expression and are larger than controls. Cells were gated on CD8 SP from (A). The solid
line represents MigR1 and the shaded line represents H-Y thymocytes, respectively. (C) Notch-expressing H-Y thymocytes display retarded
CD8 SP development in comparison to vector control H-Y thymocytes when electronically gated on small thymocytes. ICN11 and control
DP cells expressed comparable levels of transgenic TCR in both cases. The y axis of each histogram represents cell number. The results are
representative of two independent experiments.
inhibitory influence of activated Notch1 on DP matura- but very low levels at the DP stage (Hasserjian et al.,
1996; Deftos et al., 2000), are fully consistent with thetion and also indicated that the level of ICN1 expression
varied inversely with the ability of cells to mature in perspective that a reduction in Notch1 activity is critical
for successful maturation to the SP lineages. Interest-response to TCR engagement. ICN1 expression corre-
lated inversely with the ability of cells to upregulate the ingly, failure to downregulate Notch signaling at the DP
stage not only results in developmental arrest but alsoactivation markers CD5 and CD69 in response to TCR-
mediated signals, raising the possibility that Notch1 appears to foster malignant transformation, as revealed
in human T-ALLs with a t(7;9) translocation.influences T cell development by attenuating TCR-medi-
ated signals. This possibility was confirmed by the ob- Our data showing that Notch1 expression inhibits
TCR- and PMA/ionomycin-induced transcription fromservation that ICN1 expression directly inhibited NFAT/
AP1 promoter activity in Jurkat T cells stimulated with an NFAT/AP-1 reporter in Jurkat cells indicate that
Notch influences TCR signaling at a level upstream ofanti-TCR or PMA and ionomycin.
These results bear directly on our understanding of NFAT/AP-1 activity but downstream of the protein ki-
nase C/Ca21-calcineurin pathway. The exact level atthe physiological significance of Notch expression in
developing T cells. Clearly, Notch activity is required which Notch exerts its effect is unclear and may be a
direct or indirect consequence of Notch activity. Notchfor the earliest stages of T cell commitment. This was
demonstrated by both inducible Notch1 KO mice that is generally perceived as a regulator of transcription due
to its ability to transform CSL from a transcriptionalexhibit a severe block in T cell development at the DN
stage (Radtke et al., 1999) and our previous studies in repressor into a transcriptional activator. However,
Notch1 may also influence cytoplasmic events via Del-which constitutive Notch1 activity drove hematopoietic
progenitors to the DP stage of development in the ab- tex, which appears to be CSL independent (Diederich
et al., 1994; Weinmaster, 1998). Deltex has been shownsence of a thymus (Pui et al., 1999). In contrast, our
present findings show that Notch activity is incompatible to inhibit ras signaling (Ordentlich et al., 1998), sug-
gesting that the effect of Notch signaling on T cell devel-with further maturation and will inhibit the DP to SP
transition by abrogating TCR signaling. Observations opment may occur via nuclear and cytoplasmic signals.
It is of interest that AP-1 is regulated by the ras/MAPKthat normal thymocytes have relatively high levels of
Notch1 expression and activity (as revealed by the sur- (ERK) signaling pathway, which influences DP matura-
tion in a dose-dependent manner (Sugawara et al., 1998;rogate markers Hes1 and Deltex) before the DP stage,
Notch1 Regulation of CD4 and CD8 Development
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Delgado et al., 2000). Studies suggest that ERK activity toward CD4 development at the expense of CD8 SP
promotes maturation and high levels favor CD4 develop- maturation (Yasutomo et al., 2000).
ment over CD8 development (Sharp et al., 1997; Bomm- These findings, together with our results, have led
hardt et al., 1999; Sharp and Hedrick, 1999). The recip- us to advance a model that may unify the apparently
rocal influence of Notch on development raises the discrepant results. Specifically, our observation that
provocative possibility that Notch1 influences matura- Notch modulates TCR signaling in a dose-dependent
tion by abrogating the consequences of ERK activity. manner, and recent indications that TCR signal strength
In fact, Notch has been shown to inhibit ras signaling determines the maturation fate of DP thymocytes (Her-
in some assays (Ordentlich et al., 1998). Observations nandez-Hoyos et al., 2000; Lin et al., 2000; reviewed in
that NFAT4-deficient mice exhibit impaired develop- Basson and Zamoyska, 2000), leads us to propose that
ment of SP thymocytes (Oukka et al., 1998) are also Notch1 regulates lineage commitment by modulating
consistent with our observation that activated Notch1 TCR signaling. First, as described here, LTR-driven full-
blocks SP maturation. length intracellular Notch will be functionally expressed
However, it is important to recognize that Notch sig- at high levels throughout DP development and therefore
naling influences other pathways in addition to NFAT/ will reduce TCR signaling significantly and inhibit matu-
AP-1. For instance, it has been shown that Notch signal- ration of all SP thymocytes. Second, truncated Notch1
ing inhibits E2A and promotes expression of HES-1, transgenes driven by the lck-proximal promoter (Allen
Deltex, pre-Ta, Meltrin, and Ifi-204, all of which can mod- et al., 1992) are less functionally active and will decrease
ulate signaling pathways (Ordentlich et al., 1998; Pui in expression during DP development, thereby reducing
et al., 1999; Deftos et al., 2000). Notch1 signaling may TCR signaling less drastically. We predict that both pub-
therefore integrate multiple signals, and its conse- lished Notch transgenes supply functional Notch1 doses
quences are likely to be context dependent. Our ability that titrate TCR signaling to a level that biases develop-
to assay the effects of Notch signaling on T cell develop- ment to the CD8 lineage. The precise phenotypes proba-
ment both in vivo and in vitro should allow us to refine our bly differ because of variation in Notch constructs, which
understanding of its specific effects on TCR signaling. result in differences in the functional dose of Notch1
Our findings that high levels of Notch1 activity abro- in each system, as described above. Finally, antisense
gate T cell development differ from other observations Notch1 (Yasutomo et al., 2000) would reduce Notch ex-
of Notch activity described in the literature (Robey et pression below its endogenous level, permitting high
al., 1996; Deftos et al., 2000; Yasutomo et al., 2000) and levels of TCR signaling, which would preferentially pro-
suggest that differences in functional Notch dose may duce CD4 T cells. The exact effect of Notch dose on
underlie these disparate results. In the first report of lineage commitment would, of course, vary with the af-
Notch activity on T cell development, an active Notch1 finity of the TCR for its positive selecting ligand.
transgene induced a distinct bias in development to- In summary, the data presented in this study demon-
ward the CD8 SP lineage rather than a general abroga- strate that expression of high levels of full-length acti-
tion of maturation. This system differs from the retroviral vated Notch1 abrogates maturation to both CD4 and
system described in this report in two important re- CD8 lineages. Further, our data suggest that the ability of
spects. First, the Notch1 transgene is driven by the lck Notch1 to abrogate TCR signaling in a dose-dependent
proximal promoter, which decreases in activity during manner may underlie its multiple effects on T cell devel-
DP thymocyte maturation (Allen et al., 1992). In contrast, opment as reported in the literature. Notch dose has
the retroviral LTR promoter is active throughout T cell been shown to regulate developmental decisions in a
development and, in particular, throughout the DP to variety of organisms (Artavanis-Tsakonas et al., 1995),
SP transition. Second, the Notch transgene used by and our results indicate that this property applies to T
Robey et al. (1996) lacks the 39 transactivation domain lymphocyte development as well.
that appears to enhance Notch function (Aster et al.,
2000). Therefore, it is likely that the transgenic Notch in Experimental Procedures
this previous report is expressed at a lower functional
dose than the retroviral Notch described here. Plasmids
The plasmids Mig ICN1, comprising the entire Notch1 intracellularRecently, another Notch1 transgenic mouse has been
domain (amino acids 1760–2555) (Aster et al., 2000), and MigR1developed (Deftos et al., 2000). It is also driven by the
(Pear et al., 1998) have been previously described. MSCV ires NGFRproximal lck promoter and includes more 39 sequence
is identical to MigR1 except “ires GFP” of Mig R1 is replaced bythan the previous lck Notch transgenic (Robey et al.,
the ECMV ires cloned in frame to the truncated human nerve growth
1996); however, it lacks the C-terminal PEST sequence factor receptor (tNGFR), which encodes the extracellular and trans-
of ICN1. We have shown that removal of the C-terminal membrane domains of hNGFR (Reddy et al., 1990). To date, identical
PEST sequence decreases transcriptional activation of results have been obtained with the “ires GFP” and “ires tNGFR”
constructs (data not shown).a HES-1 reporter (Aster et al., 2000), suggesting that
this form of Notch is not equivalent to the full-length
Retrovirus Productionintracellular Notch construct used here (ICN1), and is
Retroviral supernatants were prepared from either Bosc (Pear et al.,again likely to be expressed at a lower functional dose.
1993) or Phoenix-E cells (Costa et al., 2000) as previously describedDevelopment of thymocytes to both CD4 and CD8 SP
(Pui et al., 1999). Retroviral supernatants were collected 48 hr post
lineages was observed using this transgenic construct, transfection, snap frozen, and stored at 2808C until used.
but there was a still a strong bias toward CD8 develop-
ment. Finally, an antisense Notch1 construct, which Mice and Bone Marrow Transduction
would be expected to decrease Notch1 expression be- All experiments were conducted in accordance with National Insti-
tutes of Health guidelines for the care and use of animals and withlow endogenous levels, has demonstrated a skewing
Immunity
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an approved animal protocol from the University of Pennsylvania MoFlo cell sorter (Cytomation Inc, Fort Collins, Colorado). A mini-
mum of 4 3 104 cells of each sorted population were permeabilizedAnimal Care and Use Committee. Young C57BL6 (B6), BALB/c, and
H-Y (C57BL/10AiTac-TgN[TCRHY]) mice were obtained from Ta- by addition of a 2% paraformaldehyde/0.1% Tween-20 solution for
30 min at room temperature. Following permeabilization, the cellsconic Farms. DO11.10 mice were kindly provided by Dr. L. Turka’s
laboratory (U. Penn.). Transduction of wild-type and TCR transgenic were incubated with either a Notch-specific antiserum (Pui et al.,
1999) or preimmune antiserum. Cells were washed and incubatedBM cells with normalized retroviral supernatants and transplantation
of these cells into lethally irradiated (900R) 4- to 8-week-old female with a phycoerythrin (PE)-conjugated goat-anti-rabbit antibody
(Southern Biotechnology Associates, Inc, Birmingham, AL) (1 mg/syngeneic recipients were performed as described (Pui et al., 1999;
Aster et al., 2000). Recipients were sacrificed at the indicated time ml). Flow cytometric analysis was performed using a FACScan in-
strument.points, and single-cell suspensions were prepared from BM and/or
thymus.
In Vitro CD4 Differentiation Cultures and Analysis
Transduction of Fetal Liver Cells and Fetal Thymic Reconstitution of TCR Stimulation
Fetal liver reconstitution of fetal thymic organ culture method was A two-step culture system was utilized. During the first step, the
performed as described (Jenkinson et al., 1982). In brief, gestation signaling culture, purified DP thymocytes (1 3 106) were cultured
day 15 fetal liver cells (B6) were spun over a ficoll gradient for 10 for 16 hr at 378C in 5% CO2-humidified air atmosphere in 1 ml of
min at 1400 3 g at room temperature with no brake. Cells at the complete medium on 24-well plates coated overnight with 10 mg/
interface were washed once in PBS and resuspended at a concen- ml anti-TCR (H57-597) and 10 mg/ml anti-CD2 (RM2-5). During the
tration of 1–2 3 106/ml in 2 ml Iscove Modified Dulbecco’s media second step, the recovery culture, cells from individual signaling
containing 10% FCS, 2 mM glutamine, 0.5 mM pen/strep (complete cultures were then transferred into uncoated wells for an additional
IMDM), 50 ng/ml SCF, 6 ng/ml IL-3, 4 ng/ml IL-1b, and 1 ng/ml 16 hr before harvesting and analysis by flow cytometry. CD5 and
IFN-g. The following day, fetal liver cells were cocultured with 50% CD69 upregulation were assessed in cells directly after the 16 hr
(v/v) of the appropriate retroviral supernatant keeping the identical signaling culture period.
cytokine concentrations and spun at 1100 3 g for 50 min at room
temperature (258C) twice, 6–8 hr apart. One day later, 1 3 105 fetal
Intrathymic Injectionliver cells were washed and placed in hanging drops for 24 hr in 30
Intrathymic injection was performed as described (Bhandoola et al.,ml in Terasaki wells with individual d15 fetal thymic lobes (harvested
1999). In brief, 1 3 106 purified DP thymocytes were isolated 4 weeksfrom the same fetuses) that had previously been irradiated with 2700
posttransplant from tNGFR-ICN1 reconstituted B6 mice (CD45.2)Rad. Subsequently, the reconstituted fetal thymic lobes were placed
and were injected into surgically revealed thymic lobes of anesthe-on 0.8 mm polycarbonate membranes (Isopore, Millipore, Ireland).
tized and unirradiated CD45.1 congenic recipients using a Hamilton
syringe. Thymocytes were harvested 3 days later and analyzed byAntibodies
flow cytometry by gating on CD45.21 cells and expression or nonex-Antibodies used for surface staining included anti-TCR (H57)-phy-
pression of tNGFR.CD41CD81 thymocytes were purified by platingcoerythrin (PE), anti-CD4-allphycocyanin (APC), anti-CD69 PE, anti-
freshly isolated thymocyte suspensions onto anti-CD8 (83-12-5, 1CD8a biotin, anti-CD24 biotin, and anti-CD5 biotin revealed with
mg/ml)-coated petri dishes. After 1 hr at 48C, nonadherent cells wereStreptavidin-Cy5 or Streptavidin RED 670 (all from Pharmingen, San
washed away and adherent cells recovered and plated for a secondDiego, CA). The TCR clonotypic antibodies were T3.70 (anti-H-Y,
time on anti-CD8 (83-12-5)-coated petri dishes. Recovered adherentgift from Dietmar Kappes, Fox Chase Cancer Center, PA) and KJ1-
cells were .95% CD41CD81. Mature T cells were enriched from26 PE (anti-DO11.10, Caltag, Burlingame, CA). Cells were stained
spleen by plating isolated spleen suspensions on petri disheswith unlabeled T3.70 and subsequently incubated with anti-mouse
coated with rat monoclonal anti-mouse IgG (200 mg/ml) to removeIgG1a-biotin and revealed with Streptavidin RED 670. The anti-
B cells. Nonadherent cells were recovered after 1 hr at room temper-NGFR antibody was prepared from supernatant obtained from 200-
ature and contained .85% CD41 or CD81 T cells. Cells were either3-G6-4 cells (ATCC clone # HB-8737) and biotinylated per the manu-
stimulated immediately after isolation or after 4 hr culture at 378C/facturer’s instructions (Molecular Probes, Eugene, OR).
5% CO2 in complete medium (RPMI, 10%FCS, 2 mM l-glutamine, 1
mM Pen/Strep, and 5 3 1025 M 2-ME).Flow Cytometry
For FACS analysis, cell suspensions from mouse BM, thymus, or
fetal liver-reconstituted fetal thymus were washed in phosphate- Transfections and Luciferase Assays
Cell transfections and luciferase assays were performed as pre-buffered saline (PBS) with 1% fetal calf serum (FCS) and 0.01%
NaN3 (FACS buffer). Fc receptors were blocked by preincubation viously described (Boerth et al., 2000). Cells were electroporated at
250V, 960 microfarads using a Gene Pulser (Bio-Rad) with 25 mg ofwith 30 ml hybridoma supernatant 2.4G2 (anti-FcR clone). Cells were
then stained with appropriately diluted fluorochrome/biotin-conju- pIL2-NFAT/AP1-luciferase, 5 mg of pCMV/b -galactosidase, and 40
mg of tNGFR or tNGFR-ICN1 expression vectors. After 24 hr, 5 3gated antibodies for 20 min at 48C and washed in 200 ml FACS
buffer. Staining with streptavidin secondaries was identical. Cells 105 cells were stimulated in triplicate for 18 hr with media, immobi-
lized anti-TCR mAb C305 (ascites 1:1000), or 12.5 ng/ml phorbolwere resuspended in 400 ml and analyzed on a Becton Dickinson
FACScalibur using Cellquest (Becton Dickinson, San Jose, CA) or ester (PMA) plus 2.5 nM ionomycin. Additionally, duplicate samples
of 5 3 105 unstimulated cells were assayed for b-galactosidaseFlowJo software (Treestar, Inc., San Carlos, CA). Routinely, 3 3 104
to 1 3 105 cells were analyzed. Dead cells were excluded. Addition- activity using the Galacto-Light Plus Reporter Gene Assay System
(Tropix Inc., Bedford, MA). Luciferase activity was determined asally, ICN11 thymocytes were simultaneously sorted into one GFP-
negative and three increasingly GFP-positive populations using a described previously (Motto et al., 1996). Luciferase light units were
Figure 6. Activated Notch1 Inhibits In Vitro Maturation in a Dose-Dependent Manner
Purified DP cells from wild-type thymocytes, ICN1 DP thymocytes, and DP from ICN1 bone marrow were stimulated overnight with anti-TCR/
CD2 and allowed to recover for another 24 hr, after which flow cytometry using GFP and TCR, CD4, and CD8 antibodies was performed. (A)
DP purity from wild-type thymocytes, ICN1 thymocytes (GFP1), and ICN1 bone marrow (GFP1). (B) Wild-type thymocytes differentiate toward
CD4 SP, whereas differentiation of ICN1 DP thymocytes (GFP1) toward CD4 is markedly attenuated. Bone marrow ICN1 DP cells (GFP1)
demonstrate negligible CD4 development. (C) GFP expression in wild-type (wt), ICN1 thymus, and ICN1 bone marrow. The results are
representative of three independent experiments. (D) GFP expression in wild-type (wt), ICN1 thymus, and ICN1 bone marrow. Note that there
are both hi and lo GFP populations within the ICN1 thymus. (E) The ability to develop toward CD4 SP is inversely correlated to the level of




Figure 7. Activated Notch1 Abrogates Acute TCR-Mediated Responses in a Dose-Dependent Manner
(A) FACS sorting gates of 4 thymic populations of increasing GFP expression (I-IV) from a lethally irradiated mouse reconstituted with ICN1
transduced bone marrow (day 34 posttransplant).
(B) Intracellular Notch protein levels correlate with GFP expression.The individual thymic populations from (A) were fixed, permeabilized, and
stained intracellularly with a Notch-specific polyclonal antibody. ICN1 levels were analyzed by flow cytometry.
(C) Both Notch DP cells from thymus and bone marrow demonstrate reduced CD5 expression compared to wild-type DP cells after TCR/CD2
ligation. GFP expression is shown in Figure 6C. Purified DP cells from wild-type thymocytes, Notch DP thymocytes, and DP from Notch bone
marrow were stimulated overnight with anti-TCR/CD2 and analyzed by flow cytometry with GFP and CD4, CD8, CD5, or CD69 antibodies the
next day.
(D) Notch DP from thymus and bone marrow exhibit reduced CD69 expression compared to wild-type DP after TCR/CD2 ligation. GFP
fluorescence is shown in Figure 6D. The ability to upregulate CD69 is inversely correlated to the level of ICN1 expression of thymic and bone
marrow DP cells. Median fluorescence intensity (MFI) for each population is shown. The results are representative of two independent
experiments.
(E) Activated Notch1 inhibits activity of the NFAT/AP-1 promoter in stimulated Jurkat cells. Jurkat T cells were transfected with pIL2-NFAT/
AP1/luciferase, pCMV/b-gal, tNGFR, or tNGFR-ICN1. Twenty-four hours following transfection, cells were left unstimulated, stimulated with
anti-TCR mAb, or stimulated with PMA plus ionomycin. The samples were assayed for luciferase activity; mean value of triplicate samples is
shown. Error bars represent the standard deviation. Luciferase light units were normalized to b-galactosidase activity for each transfection.
Relative luciferase units (RLU) are displayed on the y axis. The results are representative of three independent experiments.
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